Jiangsu GDK Valuation
| 688670 Stock | 16.68 0.39 2.39% |
At this time, the firm appears to be overvalued. Jiangsu GDK Biotechnology retains a regular Real Value of USD12.36 per share. The prevalent price of the firm is USD16.68. Our model calculates the value of Jiangsu GDK Biotechnology from evaluating the firm fundamentals such as Current Valuation of 1.82 B, return on asset of -0.0601, and Return On Equity of -0.0825 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 1.5596 | Enterprise Value 1.8 B | Enterprise Value Ebitda 151.2079 | Price Sales 39.0332 | Enterprise Value Revenue 34.5718 |
Overvalued
Today
Please note that Jiangsu GDK's price fluctuation is somewhat reliable at this time. Calculation of the real value of Jiangsu GDK Biotechnology is based on 3 months time horizon. Increasing Jiangsu GDK's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Jiangsu GDK is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Jiangsu Stock. However, Jiangsu GDK's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.68 | Real 12.36 | Hype 16.68 |
The real value of Jiangsu Stock, also known as its intrinsic value, is the underlying worth of Jiangsu GDK Biotechnology Company, which is reflected in its stock price. It is based on Jiangsu GDK's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Jiangsu GDK's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Jiangsu GDK Biotechnology helps investors to forecast how Jiangsu stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Jiangsu GDK more accurately as focusing exclusively on Jiangsu GDK's fundamentals will not take into account other important factors: Jiangsu GDK Cash |
|
Jiangsu GDK Total Value Analysis
Jiangsu GDK Biotechnology is presently forecasted to have takeover price of 1.82 B with market capitalization of 2.05 B, debt of 64.06 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Jiangsu GDK fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.82 B | 2.05 B | 64.06 M |
Jiangsu GDK Investor Information
About 77.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.56. In the past many companies with similar price-to-book ratios have beat the market. Jiangsu GDK Biotechnology recorded a loss per share of 0.92. The entity last dividend was issued on the 26th of May 2023. The firm had 1.4:1 split on the 26th of May 2023. Based on the analysis of Jiangsu GDK's profitability, liquidity, and operating efficiency, Jiangsu GDK Biotechnology is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.Jiangsu GDK Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Jiangsu GDK has an asset utilization ratio of 8.25 percent. This suggests that the Company is making USD0.0825 for each dollar of assets. An increasing asset utilization means that Jiangsu GDK Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.Jiangsu GDK Ownership Allocation
Jiangsu GDK Biotechnology has a total of 123.2 Million outstanding shares. Jiangsu GDK retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 77.29 (percent) of Jiangsu GDK outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Jiangsu GDK Profitability Analysis
The company reported the revenue of 134.59 M. Net Loss for the year was (70.99 M) with profit before overhead, payroll, taxes, and interest of 267.9 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Jiangsu GDK's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Jiangsu GDK and how it compares across the competition.
About Jiangsu GDK Valuation
The stock valuation mechanism determines Jiangsu GDK's current worth on a weekly basis. Our valuation model uses a comparative analysis of Jiangsu GDK. We calculate exposure to Jiangsu GDK's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Jiangsu GDK's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 104.7 M | 204.8 M |
Complementary Tools for Jiangsu Stock analysis
When running Jiangsu GDK's price analysis, check to measure Jiangsu GDK's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jiangsu GDK is operating at the current time. Most of Jiangsu GDK's value examination focuses on studying past and present price action to predict the probability of Jiangsu GDK's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jiangsu GDK's price. Additionally, you may evaluate how the addition of Jiangsu GDK to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |